The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation

Research output: Contribution to journalReview articlepeer-review

Abstract

The pandemic of coronavirus disease 2019 (CoVID-19) has been an unprecedented period. The disease afflicts multiple organ systems, with acute kidney injury (AKI) a major complication in seriously ill patients. The incidence of AKI in patients with CoVID-19 is variable across numerous international studies, but the high incidence of AKI and its associated worse outcomes in the critical care setting are a consistent finding. A multitude of patterns and mechanisms of AKI have been elucidated, and novel strategies to address shortage of renal replacement therapy equipment have been implemented. The disease also has had consequences on longitudinal management of patients with chronic kidney disease and end stage kidney disease. Kidney transplant recipients may be especially susceptible to CoVID-19 as a result of immunosuppression, with preliminary studies demonstrating high mortality rates. Increased surveillance of disease with low threshold for testing and adjustment of immunosuppression regimen during acute periods of illness have been recommended.

Original languageEnglish (US)
Article number449
JournalBMC nephrology
Volume21
Issue number1
DOIs
StatePublished - Dec 1 2020

Keywords

  • AKI
  • CKD
  • CoVID-19
  • Disparity
  • ESKD
  • Transplantation

ASJC Scopus subject areas

  • Nephrology

Fingerprint

Dive into the research topics of 'The COVID-19 nephrology compendium: AKI, CKD, ESKD and transplantation'. Together they form a unique fingerprint.

Cite this